@article{JTD21905,
author = {Shangbiao Li and Rui Zhu and Dianhe Li and Na Li and Xiaoxia Zhu},
title = {Prognostic factors of oligometastatic non-small cell lung cancer: a meta-analysis},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {6},
year = {2018},
keywords = {},
abstract = {Background: The prognostic factors of oligometastatic non-small cell lung cancer (NSCLC) are uncertain. We performed a meta-analysis to assess the prognostic factors of oligometastatic NSCLC patients who are most likely to achieve long-term survival.
Methods: We searched PubMed, EMBASE, the Cochrane to identify eligible articles and performed the meta-analysis of all randomized controlled trials (RCTs) and retrospective comparative studies revealing the prognostic factors of oligometastatic NSCLC. The primary endpoint of interest was overall survival (OS).
Results: We analyzed data from twenty-four eligible studies, including data from 1,935 patients with oligometastatic NSCLC. In the univariate analysis, we found no significant difference in OS of prognostic factors including age [hazard ratios (HRs) 1.02, 95% CI: 0.80–1.31, P=0.86], smoking status (HR 1.08, 95% CI: 0.80–1.46, P=0.62), type of metastases (HR 1.61, 95% CI: 0.86–3.03, P=0.14), but significantly positive prognoses containing female (HR 1.21, 95% CI: 1.02–1.45, P=0.03), (y)pN0 stage (HR 1.82, 95% CI: 1.40–2.36, P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21905}
}